The Hyperthyroidism Market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.1 billion by 2034, registering a CAGR of 5.2%. This growth trajectory is underpinned by several factors, including the rising prevalence of hyperthyroidism, increased awareness of thyroid disorders, and advancements in diagnostic and therapeutic technologies. The growing geriatric population, which...